Consistent with this, inhibition of IGF-IR causes sensitization to cisplatin (98, 131, 132), doxorubicin, and trabectedin (133), as well as ionizing radiation (129, 134–136) in ovarian, prostate, colon, and breast cancer cells and in mouse xenograft models. This evidence concerns the gene IGF1R and breast carcinoma.